How does omalizumab compare with oral immunotherapy for treating multiple food allergies? In this episode of **Hope & Histamine: The Paediatric Allergy Podcast**, we explore **OUtMATCH Stage 2**, comparing omalizumab (Xolair) with omalizumab-facilitated multi-allergen oral immunotherapy (OIT).
We unpack the findings on treatment success, allergic reactions, side effects and treatment discontinuation—and explain why tolerability matters when interpreting the results. What do these findings mean for children with peanut allergy and other food allergies, their families, and the clinicians supporting them?
Join us for an accessible, evidence-based discussion of anti-IgE therapy, food allergy desensitisation and personalised treatment decisions. Whether you’re a paediatrician, allergist, trainee or parent, discover what the OUtMATCH trial adds to the evolving conversation about multifood allergy treatment.
**Sources:**
1. Wood, R.A. et al. (2024) 'Omalizumab for the Treatment of Multiple Food Allergies', *New England Journal of Medicine*, 390(10), pp. 889–899. doi: 10.1056/NEJMoa2312382.
2. Wood, R.A. et al. (2026) 'Treatment of Multifood Allergy With Omalizumab or Multiallergen Oral Immunotherapy: A Randomized Clinical Trial', *JAMA Pediatrics*, Advance online publication. doi: 10.1001/jamapediatrics.2026.2910.
🎧 Listen now on **Apple Podcasts, Spotify, Amazon Music, and YouTube**
**Disclaimer:** The information shared in this podcast and on this website is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions you may have about a medical condition. Please don't ignore or delay seeking medical advice based on content from this podcast or website.
**Buy me a coffee:** https://coff.ee/goodlifecreations
**Hope & Histamine: The Paediatric Allergy Podcast** brings you expert interviews, evidence-based discussions and practical clinical updates on paediatric allergy, immunology and related conditions to support healthcare professionals in everyday practice.
**🎧 Listen and subscribe:**
**https://hopeandhistaminepodcasts.buzzsprout.com**
If you enjoyed this episode, please subscribe, leave a review, and share it with colleagues to help advance the care of children with rare allergic and immunological conditions.
Send us Fan Mail
Support the show
**Brought to you by** - Goodlife Creations (2026).
**Music by** - Denys Kyshchuk from Pixabay.